)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
RPG Life Sciences
RPG Life Sciences (RPGLIFE) investor relations material
RPG Life Sciences Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 25/26 earnings summary30 Apr, 2026
Executive summary
Achieved robust Q4 FY26 performance with revenue up 23.6% year-over-year and PAT (excluding exceptionals) up 58.1%, driven by strong domestic formulation growth and API recovery.
Outperformed the Indian pharma market, ranking as the 4th fastest-growing pharma company among the top 50 in Q4 FY26 and improving IPM ranking from 58 to 52.
Maintained a strong product portfolio with focus on chronic and specialty therapies, and continued expansion in domestic and international markets.
Audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, were approved, with unmodified auditor opinions confirming compliance and fair presentation.
A final dividend of Rs. 24 per share (300% of face value) was recommended for FY 2025-26, subject to shareholder approval.
Financial highlights
Q4 FY26 revenue from operations: INR 176.9 crore (₹176.9 crore), up 23.6% from INR 143.1 crore in Q4 FY25.
Q4 EBITDA: INR 45.2 crore (25.6% margin), up 48% year-over-year; Q4 PAT (excluding exceptionals): INR 29.3 crore, up 58.1%.
FY26 revenue: INR 707.5 crore (Rs. 70,752 lakhs), up 8.3% year-over-year.
FY26 EBITDA: INR 172.7 crore (24.4% margin), nearly flat year-over-year; FY26 PAT (excluding exceptionals): INR 111.7 crore, nearly flat year-over-year.
Net profit for FY 2025-26 was Rs. 11,517 lakhs, compared to Rs. 18,324 lakhs in the previous year.
Outlook and guidance
Expectation of sustained growth in domestic, API, and international segments, with API positioned as a key growth driver.
Margin stabilization anticipated with API plant fully operational; gross margins expected to remain consistent.
Growth to be driven by volume expansion, new product launches, and higher-margin introductions.
The transfer of the API division to a wholly owned subsidiary, RPG Active Pharma Limited, is pending regulatory approvals.
Continued investments in R&D, digital initiatives, and manufacturing capacity to support future growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from RPG Life Sciences
- 9M FY26 revenue up 4% YoY, margins down; API transfer to boost focus, debt-free status kept.RPGLIFE
Q3 25/2627 Jan 2026 - Land monetization and MIDC charges will fund future M&A and growth, boosting cash reserves.RPGLIFEStatus Update20 Jan 2026
- Double-digit growth, record margins, and strong cash flows drive robust H1 FY25 results.RPGLIFEQ2 24/2515 Jan 2026
- Net profit and revenue surged on core growth and land sale, with strong margins and dividends.RPGLIFEQ4 24/257 Jan 2026
- Q2 saw 17.2% domestic growth, strong margins, API recovery expected, and A+ rating maintained.RPGLIFEQ2 25/2614 Dec 2025
- FY24 saw robust growth, margin expansion, and strategic advances in products and ESG.RPGLIFEInvestor Presentation20 Oct 2025
- Q1 FY25 saw robust growth, margin expansion, and a debt-free, well-audited performance.RPGLIFEQ1 24/2520 Oct 2025
- Double-digit revenue and profit growth, strong margins, and a one-time charge in Q3 FY25.RPGLIFEQ3 24/2520 Oct 2025
- Revenue dipped year-over-year as API sales fell, but sequential profit growth and capex continued.RPGLIFEQ1 25/2620 Oct 2025
Next RPG Life Sciences earnings date
Q1 26/2724 Jul, 2026
RPG Life Sciences
Next RPG Life Sciences earnings date
Q1 26/2724 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage